Another Alzheimer's drug debuts

Posted: February 27, 2002

WASHINGTON — An experimental drug that works to calm brain activity could help patients with moderate to severe Alzheimer's disease just as they lose the ability to care for themselves, researchers said yesterday.

The drug, Memantine, slows over-excited brain cell signaling and, in doing so, it slows the progression of the disease, which gradually robs patients of their ability to remember, to find their way around, and to care for themselves, researchers told the American Association for Geriatric Psychiatry in Orlando.

There is no cure for Alzheimer's, which affects 4 million Americans. Current drugs, such as Aricept, only slow progression in its early stages.

_ With tick season approaching, the maker of Lymerix, the nation's only vaccine against Lyme disease, pulled it off the market, citing lack of demand.

|
|
|
|
|